JOHN TUMEH: Open Payments
NPI 1053540088 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,629 in 46 payments from 18 companies in 2025. Trend: 2023 $1,507 · 2024 $3,023 · 2025 $1,629
Food & beverage: $1,429Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $226 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Axsome Therapeutics, Inc. | 5 | $183 |
| JAZZ PHARMACEUTICALS INC. | 2 | $151 |
| ABBVIE INC. | 9 | $151 |
| Supernus Pharmaceuticals, Inc. | 3 | $146 |
| Otsuka America Pharmaceutical, Inc. | 7 | $140 |
| Forte Bio-Pharma LLC | 1 | $88 |
| EMD Serono, Inc. | 1 | $77 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
Products named: SPRAVATO, Auvelity, XYWAV, VRAYLAR, REXULTI, TANLOR, INGREZZA, Qelbree.
Industry payments across GA — which companies pay providers there.
